Microbiome in 3P Medicine Strategies
The First Exploitation Guide
Springer
ISBN 978-3-031-19566-2
Standardpreis
Bibliografische Daten
Fachbuch
Buch. Softcover
2024
1 s/w-Abbildung.
In englischer Sprache
Umfang: xv, 425 S.
Format (B x L): 15,5 x 23,5 cm
Gewicht: 759
Verlag: Springer
ISBN: 978-3-031-19566-2
Produktbeschreibung
Already well-acknowledged as well as future advantages of application of pre-, pro- and pharma-biotics are detailed in the book.
Socio-economic impacts of the area are considered in the context of the entire spectrum of healthcare services from disease care provided to patients up to health care provided to persons in suboptimal health conditions.
Innovative technologies including phenotyping, genotyping, individualised profiling, patient stratification, big data analysis, and multi-omics, amongst others are all involved in the book.
The book is unique from view point of multi-professional expertise involved. International network presents more than 10 countries worldwide including Belgium, China, Germany, Israel, Ukraine and USA. The data presented are of great scientific value and of particular importance for educating a broad spectrum of professionals including researchers, healthcare givers, policy makers, business people, policy makers and general population.
Autorinnen und Autoren
Kundeninformationen
Provides a unique attempt to make a bridge between human microbiome and real protocols for medical practice Offers a new vision on human microbiome data as an instrument of personal health and disease balance Summarizing probiotics efficacy data within the prism of 3P medicine approach
Produktsicherheit
Hersteller
Springer Nature Customer Service Center GmbH
ProductSafety@springernature.com